A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants
Clinical trial NCT05136677 · COMPLETED
Trial details
- NCT number
- NCT05136677
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-25
- Primary completion
- 2025-11-12
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.